WAYNE, Pa., — Bracket, a leading clinical trial technology and specialty services provider, today announced the addition of Christopher Crucitti, Chief Commercial Officer to its global executive team. Crucitti joins Bracket as an experienced commercial leader in clinical and R&D services.
Crucitti brings industry-recognized experience, knowledge and integrity to Bracket’s leadership team as well as notable accomplishments in training and motivating other commercial professionals to provide a high level of customer service and overall performance. He will be responsible for the global commercial strategy and development of Bracket’s electronic clinical outcomes assessments (eCOA) and patient engagement platform, Randomization and Trial Supply Management (RTSM), Rater Training and Quality Assurance as well the Company’s expanding mobile suite for patient diary and analytics, among others.
“It’s with great excitement that we welcome Chris to our leadership team,” said Jeff Kinell, CEO at Bracket. “Chris brings an impressive resume in clinical commercial strategy to Bracket and has joined us at a pivotal time, as we continue to position ourselves competitively in the global marketplace through the increased use of Bring Your Own Device mobile solutions for patient engagement. We look forward to the unique and seasoned perspective Chris will bring to our team and global commercial strategy.”
Prior to joining Bracket, Crucitti served as Chief Commercial Officer at Science Exchange, a world-leading marketplace for outsourced research and as Executive Vice President, Global Business Development at Worldwide Clinical Trials, Inc., a global CRO that provides full-service drug development services to the pharma and biotech industries. Crucitti also held senior roles at InVentiv Health Clinical and i3 Research, a pharmaceutical services company that provides integrated solutions throughout the product lifecycle.
“I’m extremely excited to join Bracket, with its many smart and committed team members, leveraging my experience in clinical development services and technology to further optimize our commercial growth strategy,” said Crucitti, Chief Commercial Officer at Bracket. “With recent and imminent expansion on the horizon, the ability to communicate how our suite of technologies and solutions empower patient engagement to ultimately improve outcomes will be paramount; I look forward to the challenge and the many opportunities to expedite the process of getting meaningful treatments in the hands of patients that need them.”
Crucitti earned his Masters of Science in Health Management from American University and his Bachelors of Science in Cardiac Rehabilitation and Exercise Science from Ithaca College.
Bracket, with ten offices and more than 800 employees worldwide, is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. Bracket eCOA™ is a flexible platform for electronic clinical outcomes assessments. Bracket RTSM™ is a best-in-breed, scalable and configurable clinical IRT solution for the life sciences industry. Bracket SmartSupplies™ is a proven platform for improving a clinical supply chain. Bracket Rater Training and Quality Assurance improve outcomes through customized training and quality assurance programs.